Clinical Trial Update: Ganciclovir 0,15% Ophthalmic Gel in the Treatment of Adenovirus Keratoconjuntivitis [NA]

View source ↗

Summary

Completed clinical trial evaluating ganciclovir 0.15% ophthalmic gel for adenoviral keratoconjunctivitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenoviral Keratoconjunctivitis
• Viral Conjunctivitis

Drugs mentioned

• Ganciclovir 0.15% ophthalmic gel (ganciclovir)

Snippet

Sponsor: Federal University of São Paulo | Conditions: Conjunctivitis, Viral, Adenoviridae Infections | NA | Status: COMPLETED